Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07571941
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy UniversityNot Yet Recruiting
NCT07571941Not Yet Recruiting
—
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy Universit...
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07573800
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07573800Not Yet Recruiting
Not Applicable
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International Univ...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
Completed1 (5%)
Unknown1 (5%)
Not Specified7 (35%)
not_applicable7 (35%)
Phase 23 (15%)
Phase 12 (10%)
Phase 41 (5%)